e-learning
resources
London 2016
Sunday, 04.09.2016
Possible phenotypes of bronchiectasis and exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Bronchiectasis is common in severe asthma
Christina Triantafyllidou (Athens, Greece), Katerina Dimakou, Adamantia Liapikou, Michail Toumbis, Anna Gkousiou, Serafeim Chrysikos, Kyriaki Tsikritsaki, Loukas Thanos, Christina Triantafyllidou
Source:
International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Session:
Possible phenotypes of bronchiectasis and exacerbations
Session type:
Poster Discussion
Number:
1546
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Christina Triantafyllidou (Athens, Greece), Katerina Dimakou, Adamantia Liapikou, Michail Toumbis, Anna Gkousiou, Serafeim Chrysikos, Kyriaki Tsikritsaki, Loukas Thanos, Christina Triantafyllidou. Bronchiectasis is common in severe asthma. Eur Respir J 2016; 48: Suppl. 60, 1546
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Bronchiectasis in severe uncontrolled asthma: A common feature
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
Sesonal variations of severe asthma exacerbations in the US
Source: International Congress 2014 – Risk factors for respiratory disease
Year: 2014
Factors associated with irreversible airway obstruction in patients with asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Nasal symptoms and doctor-diagnosed chronic lung diseases
Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Year: 2013
Predictors of exacerbations in patients with bronchiectasis
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Prevalence of refractory asthma in population with severe asthma
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Characteristics of patients with persistent airflow obstruction from an asthma clinic
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
Exacerbations of bronchiectasis: Etiology and outcome
Source: International Congress 2016 – Orphan diseases II
Year: 2016
Community acquired pneumonia in asthma patients
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013
Early- and late-onsets of severe asthma are associated with divergent phenotypes of the disease
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Late-onset hypereosinophilic asthma accompanied by systemic eosinophilic manifestations
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016
Exacerbations and symptoms remain common in patients with asthma control: A survey of 8000 patients in Europe
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013
Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016
Comparison of clinical features of severe persistent asthma and refractory asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
Predictors of exacerbations in asthma
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation?
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Asthma diagnosis in children with community-acquired pneumonia: New challenges
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016
Recurrent exacerbation of asthma: Characteristics of the patients and risk factors
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Characterization of asthma exacerbations in outpatients – National survey
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
Patients with allergic and eosinophilic asthma in the German severe asthma registry
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept